Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

10 U.S. Charity Staff to Leave Sierra Leone Amid Ebola Scare

March 16, 2015 8:27 am | by Clarence Roy-Macaulay and Robbie Corey-Boulet, Associated Press | News | Comments

Ten health care workers with a Boston-based nonprofit organization responding to Sierra Leone's Ebola outbreak are to be evacuated to the United States. Read more...


Anti-Herpes Drug May Help Control HIV

March 13, 2015 1:56 pm | by Stephanie Guzowski, Editor | News | Comments

A drug that’s used to control herpes simplex virus 2 (HSV-2) could reduce levels of HIV in patients who do not have genital herpes, finds a National Institutes of Health (NIH) study. Read more...


Diabetes Drug Shown Not to Increase Heart Failure Risk

March 13, 2015 12:17 pm | by University of Connecticut | News | Comments

People with the most common form of diabetes can take the new drug Alogliptin without concern for an increased risk of heart failure or cardiovascular disease, according to research by a UConn cardiologist published in the British medical journal, The Lancet. Read more..


Antibiotics Found to Have Unexpected Effects on Mitochondria

March 13, 2015 12:03 pm | News | Comments

An EPFL study has shown that tetracycline-based antibiotics have an unexpected effect on the development of many organisms. In addition to pointing out the issue of soil pollution by these antibiotics, which are widely administrated to livestock, the scientists call upon colleagues to explore the consequences of using them in experiments that modulate gene expression. Read more...

Depomed Secures $575M Debt Facility From Deerfield, Pharmakon

March 13, 2015 11:57 am | News | Comments

Depomed, Inc. announced that it has entered into a definitive agreement with Deerfield and Pharmakon Advisors, LP to borrow $575 million.  The proceeds of the loan will be used to fund the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. which Depomed announced on January 15, 2015.  Read more...

Immunotherapy: New Hope for Patients with Advanced Lung Cancer

March 13, 2015 11:52 am | by Columbia University | News | Comments

In the late 1800s, a New York surgeon named William Coley noticed that some patients with cancer seemed to fare better if they developed an infection after undergoing surgery. Suspecting that the immune system played a role in this mysterious response, he tried treating cancer patients with bacteria in an effort to turn on the immune system. Read more...


Stem Cells Lurking in Tumors Can Resist Treatment

March 13, 2015 11:35 am | by Washington University in St. Louis | News | Comments

Scientists are eager to make use of stem cells’ extraordinary power to transform into nearly any kind of cell, but that ability also is cause for concern in cancer treatment. Malignant tumors contain stem cells, prompting worries among medical experts that the cells’ transformative powers help cancers escape treatment. Read more...


Study Shows Two New Flu Strains Do Not Yet Easily Infect Humans

March 13, 2015 10:00 am | by The Scripps Research Institute | News | Comments

Scientists have analyzed a key protein from two influenza strains that recently began causing sporadic infections among people in China and Taiwan. Read more...


More Children at Risk of Measles in Wake of Ebola Epidemic

March 13, 2015 9:30 am | by Lauran Neergaard, AP Medical Writer | News | Comments

Ebola's toll moved beyond 10,000 deaths Thursday even as researchers warned of yet another threat to hard-hit West Africa. Read more...


Actavis Gains FDA Approval for Treatment of Pediatric Bipolar Disorder

March 13, 2015 9:24 am | News | Comments

Approximately 1.2 million children and teens in the United States meet the criteria for bipolar I disorder. Read more...


Cholera Vaccine Succeeds in Rural Haiti

March 13, 2015 9:14 am | by Jake Miller, Harvard Medical School | News | Comments

A vaccination campaign that almost didn’t happen was widely effective in reducing transmission of cholera in the midst of an ongoing outbreak of the disease in rural Haiti. Read more...


UN Tally of Ebola Deaths Passes 10,000

March 13, 2015 9:05 am | by Maria Cheng, Associated Press | News | Comments

Most of the deaths were in West Africa.


Washington State Mandate Will Raise Prescription Drug Costs for State Programs, Employers, Unions

March 12, 2015 1:51 pm | News | Comments

A bill (S.B. 5857) in the Washington legislature would force employers, unions, taxpayers, and public programs to pay drugstores more for prescription drugs, the Pharmaceutical Care Management Association (PCMA) said today. Read more...


Genetic Test Maker 23AndMe Launches Drug R&D Effort

March 12, 2015 1:45 pm | by Matthew Perrone, Associated Press | News | Comments

Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines. Read more...                      


Harder-to-Abuse OxyContin Doesn’t Stop Illicit Use

March 12, 2015 1:40 pm | by Jim Dryden, Washington University in St. Louis | News | Comments

A reformulation of OxyContin that makes it harder to abuse has curtailed the drug’s illicit use. But some 25 percent of drug abusers entering rehab said they still abused the prescription painkiller despite package labeling that emphasizes its abuse-deterrent properties, new research indicates. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.